Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Am J Med Genet A. 2019 Jan 24;179(3):498–502. doi: 10.1002/ajmg.a.61046

Table 2.

Summary of clinical features of ALG11-CDG patients

Developmental disability Epilepsy Dysmoprhic features Microcephaly Hypotonia Hypertonia (peripheral) Hyperreflexia Deafness Eye/visual problems Feeding problems
12/12 (100%) 12/12 (100%) 6/7 (86%), [5 pts NA] 9/10 (90%) [2 pts NA] 11/12 (92%) 6/10 (60%) [2 pts NA] 4/6 (66%) [6 pts NA] 4/7 (57%) [5 pts NA] 10/11 (91%) [1 pt NA] 7/12 (58%)